These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24521008)

  • 1. Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient.
    Anbar TS; Hegazy RA; Picardo M; Taieb A
    Exp Dermatol; 2014 Apr; 23(4):219-23. PubMed ID: 24521008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo treatment demystified: a flowchart for stratified treatment approaches.
    Tung R; Le Poole IC
    Exp Dermatol; 2014 Jul; 23(7):469-70. PubMed ID: 24806714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo nonsurgical treatment: a review of latest treatment researches.
    Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
    Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
    Vanscheidt W; Hunziker T
    Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The practice guideline 'vitiligo'].
    Menke HE; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1976-81. PubMed ID: 17002186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of vitiligo with phenylalanine and UV-A].
    Rosenbach T; Wellenreuther U; Nürnberger F; Czarnetzki BM
    Hautarzt; 1993 Apr; 44(4):208-9. PubMed ID: 8482598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
    Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
    Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
    Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
    Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo road map.
    Lee BW; Schwartz RA; Hercogová J; Valle Y; Lotti TM
    Dermatol Ther; 2012; 25 Suppl 1():S44-56. PubMed ID: 23237038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo.
    Picardo M; Dell'Anna ML; Ezzedine K; Hamzavi I; Harris JE; Parsad D; Taieb A
    Nat Rev Dis Primers; 2015 Jun; 1():15011. PubMed ID: 27189851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous repigmentation in vitiligo: why it is important.
    Malakar S; Lahiri K
    Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of stable vitiligo hands by ReCell system: a preliminary report.
    Cervelli V; Spallone D; Lucarini L; Palla L; Brinci L; De Angelis B
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):691-4. PubMed ID: 20707289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroxyacetone: a safe camouflaging option in vitiligo.
    Rajatanavin N; Suwanachote S; Kulkollakarn S
    Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: an observational study.
    Garg T; Chander R; Jain A
    Dermatol Surg; 2011 Dec; 37(12):1763-6. PubMed ID: 21834930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermabrasion may repigment vitiligo through stimulation of melanocyte precursors and elimination of hyperkeratosis.
    Awad SS
    J Cosmet Dermatol; 2012 Dec; 11(4):318-22. PubMed ID: 23174056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.